Melasma in men

Journal of Cosmetic Dermatology

Volumn 11, Issue 2, 2012, Pages 151-157

  Vachiramon, Vasanop ^a   Suchonwanit, Poonkiat ^a   Thadanipon, Kunlawat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chemical peels; Hydroquinone; Hyperpigmentation; Laser treatment; Melasma; Men

Indexed keywords

ANTICONVULSIVE AGENT; COSMETIC; GLYCOLIC ACID; RESORCINOL; RETINOIC ACID; SALICYLIC ACID; SUNSCREEN; TITANIUM DIOXIDE; TRICHLOROACETIC ACID; ZINC OXIDE;

ACANTHOSIS NIGRICANS; BECKER NEVUS; CHLOASMA; CLINICAL FEATURE; CONTACT DERMATITIS; DERMATOLOGIST; DIFFERENTIAL DIAGNOSIS; ESTHETIC SURGERY; ETHNICITY; HEREDITY; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; LENTIGO; LICHEN PLANUS; LIGHT EXPOSURE; LOW LEVEL LASER THERAPY; MELANOSIS; MEN'S HEALTH; MIGRANT WORKER; ORAL CONTRACEPTION; OTA NEVUS; PATIENT CARE; PHOTOTHERAPY; PHOTOTOXICITY; POSTINFLAMMATORY HYPERPIGMENTATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUN EXPOSURE; THYROID DISEASE; ULTRAVIOLET RADIATION; YAG LASER;

CHEMEXFOLIATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; LASER THERAPY; MALE; MELANOSIS; SUNSCREENING AGENTS;

EID: 84861927630     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2012.00613.x     Document Type: Review

References (36)

1. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453-1457.
2. Balkrishnan R, McMichael AJ, Hu JY et al. Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol 2006; 45: 111-115.
3. Pichardo R, Vallejos Q, Feldman SR et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol 2009; 48: 22-26.
4. Werlinger KD, Guevara IL, Gonzalez CM et al. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol 2007; 143: 424-425.
5. Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin 2003; 21: 601-607.
6. Rendon MI. Utilizing combination therapy to optimize melasma outcomes. J Drugs Dermatol 2004; 3: S27-S34.
7. Sivayathorn A. Melasma in orientals. Clin Drug Investig 1995; 10(Suppl 2): 34-40.
8. Sarkar R, Jain RK, Puri P. Melasma in Indian males. Dermatol Surg 2003; 29: 204.
9. Sarkar R, Puri P, Jain RK et al. Melasma in men: a clinical, aetiological and histological study. J Eur Acad Dermatol Venereol 2010; 24: 768-772.
10. Vazquez M, Maldonado H, Benmaman C, Sanchez JL. Melasma in men. A clinical and histologic study. Int J Dermatol 1988; 27: 25-27.
11. Keeling J, Cardona L, Benitez A et al. Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. Cutis 2008; 81: 179-183.
12. Snell RS. The pigmentary changes occurring in the breast skin during pregnancy and following estrogen treatment. J Invest Dermatol 1964; 43: 181-186.
13. Sialy R, Hassan I, Kaur I, Dash RJ. Melasma in men: a hormonal profile. J Dermatol 2000; 27: 64-65.
14. Perez M, Sanchez JL, Aguilo F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol 1983; 81: 543-545.
15. Kippenberger S, Loitsch S, Solano F et al. Quantification of tyrosinase, TRP-1, and Trp-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR - regulation by steroid hormones. J Invest Dermatol 1998; 110: 364-367.
16. O'Brien TJ, Dyall-Smith D, Hall AP. Melasma of the forearms. Australas J Dermatol 1997; 38: 35-37.
17. Lonsdale-Eccles AA, Langtry JA. Melasma on the nape of the neck in a man. Acta Derm Venereol 2005; 85: 181-182.
18. Sanchez NP, Pathak MA, Sato S et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698-710.
19. Kang WH, Yoon KH, Lee ES et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002; 146: 228-237.
20. Kang HY, Hwang JS, Lee JY et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol 2006; 154: 1094-1099.
21. Sim JH, Lee EH, Kang HY et al. The histopathologic characteristics in male melasma: comparison with female melasma and lentigo. J Am Acad Dermatol 2012; 66: 642-649.
22. Fried RG. Esthetic treatment modalities in men: psychologic aspects of male cosmetic patients. Dermatol Ther 2007; 20: 379-384.
23. Schlessinger J. Skin care for men and its marketing. Dermatol Ther 2007; 20: 452-456.
24. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 2006; 55: 1048-1065.
25. Vazquez M, Sanchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. Cutis 1983; 32: 92, 5-6.
26. Buller DB, Anderson PA, Walkosz BJ et al. Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areas. J Am Acad Dermatol 2012; 66: 63-70.
27. Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol 2006; 54: S272-S281.
28. Gupta RR, Mahajan BB, Garg G. Chemical peeling - evaluation of glycolic acid in varying concentrations and time intervals. Indian J Dermatol Venereol Leprol 2001; 67: 28-29.
29. Sheth VM, Pandya AG. Melasma: a comprehensive update part II. J Am Acad Dermatol 2011; 65: 699-714.
30. Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 2005; 31: 1645-1650.
31. Goldberg DJ, Berlin AL, Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med 2008; 40: 134-138.
32. Katz TM, Glaich AS, Goldberg LH et al. Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up. Dermatol Surg 2010; 36: 1273-1280.
33. Karsai S, Fisher T, Pohl L et al. Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients. J Eur Acad Dermatol Venereol 2012; 26: 470-476.
34. Wind BS, Kroon MW, Meesters AA et al. Non-ablative 1, 550nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med 2010; 42: 607-612.
35. Zhou X, Gold MH, Lu Z, Li Y. Efficacy and safety of Q-switched 1, 064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatol Surg 2011; 37: 962-970.
36. Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1, 064nm) laser for the treatment of facial melasma in Asians. Dermatol Surg 2010; 36: 76-87.